O. Ivashchuk, V.I. Sorokin / Tetrahedron 65 (2009) 4652–4658
4657
126.61 (s, C-500 (2,3-pyrazolyl)), 108.05 (s, C-400 (2,3-pyrazolyl)),
3.3. Preparation of complexes
107.38 (s, C-40 (1,4-pyrazolyl)); m/z (EI) 342 (100, Mþ), 341 (88), 314
(13), 246 (13), 207 (13), 180 (18), 168 (23), 103 (23), 79 (34), 64 (41),
57 (44), 52 (73), 44 (76), 39 (61%).
To prepare the Cu(II) complexes, 1 or 2 equiv of CuCl2$2H2O
solution in methanol (3 mL) was added to a stirred solution of li-
gand (0.1 mmol) in CH2Cl2 (3 mL). The reaction mass was stirred
overnight, and the precipitated complex was isolated by filtration,
washed with methanol, and dried for subsequent analysis by ESI-
MS or crystal growth.
To prepare the Pd(II) complexes, 1 or 2 equiv of PdCl2(CH3CN)2
solution in CH2Cl2 (3 mL) was added to a stirred solution of ligand
(0.1 mmol) in CH2Cl2 (3 mL). The reaction mass was stirred over-
night, and the precipitated complex was isolated by filtration,
washed with CH2Cl2, and dried for subsequent analysis by ESI-MS
or crystal growth.
3.2.4. 1,4-Difluoro-2,5-bis(pyrazol-1-yl)benzene (14)
Compound 14 was prepared according to the general procedure
using DMF as the solvent and 2 equiv of nucleophile at 50 ꢀC. To
isolate 14, the crude reaction mass was separated by column chro-
matography on alumina using CHCl3/hexanes (2:1) as eluent.
Isolated yield was 36%, with colorless crystals from CHCl3, mp 140–
141 ꢀC; [Found: C, 58.54; H, 3.26; N, 22.77. C12H8F2N4 requires: C,
58.54; H, 3.27; N, 22.76%]; nmax (KBr) 3124, 1633, 1539, 1473, 1402,
1191, 1035, 937, 771 cmꢁ1
; dH (300 MHz, CDCl3) 6.49 (2H, dd, J 2.5,
1.9 Hz, H-40 (pyrazolyl)), 7.73 (2H, d, H-50 (pyrazolyl)), 7.90 (2H, dd, J
9.2, 9.2 Hz, H-3,6), 8.07 (2H, br m, H-30 (pyrazolyl)); dC (63 MHz,
CDCl3) 149.07 (dd, J 246.5, 3.7 Hz, C-1,4), 141.52 (s, C-30 (pyrazolyl)),
130.83 (dd, J 14.9, 8.3 Hz, C-3,6), 112.06 (dt, J 18.0, 5.4 Hz, C-2,5),
108.48 (s, C-40 (pyrazolyl)); dF (272 MHz, CDCl3) ꢁ128.43 (2F, dd, F-
1,4); m/z (EI) 246 (100, Mþ), 218 (4),191 (6),167 (11),152 (7),125 (7%).
3.4. X-ray crystallographic analysis
Crystals of the compounds were grown by slow evaporation of
their solutions in methanol (6$HClO4, 12, 17$2HClO4, and Pd(II)
complex of 6) or CH2Cl2 (Cu(II) complex of 10). The data were col-
lected on a Bruker SMART 1000 CCD diffractometer using Mo K
a
3.2.5. 1,2,4,5-Tetrakis(pyrazol-1-yl)benzene (5)
radiation. SHELX-97 provided the method of absorption correction,
Compound 5 was prepared according to the general procedure
using DMF as the solvent and 4 equiv of nucleophile at 50 ꢀC. Yield
was 83%, with colorless crystals from methanol, mp 204–205 ꢀC;
[Found: C, 63.12; H, 4.10; N, 32.74. C18H14N8 requires: C, 63.15; H,
4.12; N, 32.73%]; nmax (KBr) 3101, 1539, 1481, 1407, 1319, 1197, 1047,
method of solution, and refinement.18
3.4.1. Compound 6$HClO4
C12H11N4ClO4 M¼310.70, monoclinic, space group P21/c,
a¼8.6564(5), b¼14.3458(9), c¼10.6481(7) Å,
b
¼96.3130(10)ꢀ,
777 cmꢁ1
;
dH (300 MHz, CDCl3) 6.32 (4H, dd, J 2.5, 1.8 Hz, H-40
V¼1314.29(14) Å3, Z¼4,
r
¼1.570 g cmꢁ3
,
crystal size¼0.35ꢂ
(pyrazolyl)), 7.05 (4H, dd, J 0.4 Hz, H-50 (pyrazolyl)), 7.70 (4H, dd, H-
30 (pyrazolyl)), 8.09 (2H, s, H-3,6); dC (63 MHz, CDCl3) 142.01 (s, C-30
(pyrazolyl)), 133.97 (s, C-1,2,4,5), 130.68 (s, C-50 (pyrazolyl)),þ125.47
(s, C-3,6), 108.36 (s, C-40 (pyrazolyl)); m/z (EI) 342 (100, M ), 341
(47), 314 (6), 287 (6), 171 (11), 157 (12), 130 (9), 117 (9), 103 (9), 76
(20), 52 (53), 39 (35%).
0.30ꢂ0.20 mm, T¼120 K; 13,032 reflections measured, 3125 unique
(Rint¼0.0229), which were used in all calculations, cut-off criterion
I>2\s(I),
m
¼0.314 mmꢁ1, the final R and wR(F2) were 0.0423, 0.0759
(all data), residual electron density max, min 0.332, ꢁ0.441 e Åꢁ3
.
3.4.2. Compound 12
C18H14N8 M¼342.37, monoclinic, space group C2/c, a¼20.966(2),
3.2.6. 1,2,4,5-Tetrafluoro-3,6-bis(pyrazol-1-yl)benzene (16)
b¼9.0322(13), c¼9.2325(11) Å,
b
¼111.202(4)ꢀ, V¼1630.0(4) Å3,
Compound 16 was prepared according to the general procedure
using DMF as the solvent and 2 equiv of nucleophile at rt. To isolate
16, the crude reaction mass was separated by column chromato-
graphy on alumina using CHCl3 as eluent. Isolated yield was 35%,
with colorless crystals from methanol, mp 161–162 ꢀC; [Found: C,
51.04; H, 2.16; N, 19.86. C12H6F4N2 requires: C, 51.07; H, 2.14; N,
Z¼4,
r
¼1.395 g cmꢁ3, crystal size¼0.60ꢂ0.20ꢂ0.15 mm, T¼100 K;
8179 reflections measured, 1756 unique (Rint¼0.0607), which were
used in all calculations, cut-off criterion I>2\s(I),
m
¼0.091 mmꢁ1
,
the final R and wR(F2) were 0.0664, 0.0971 (all data), residual
electron density max, min 0.219, ꢁ0.240 e Åꢁ3
.
19.85%]; nmax (KBr) 3126, 1540, 1392, 1176, 1087, 987, 775 cmꢁ1
; dH
3.4.3. Compound 17$2HClO4
(300 MHz, CDCl3) 6.59 (2H, dd, J 2.5, 1.9 Hz, H-40 (pyrazolyl)), 7.77
(2H, dd, J 0.1 Hz, H-50 (pyrazolyl)), 7.87 (2H, dd, H-30 (pyrazolyl)); dC
(63 MHz, CDCl3) 142.82 (s, C-30 (pyrazolyl)), 132.24 (s, C-50 (pyr-
azolyl)), 108.22 (s, C-40 (pyrazolyl)); dF (272 MHz, CDCl3) ꢁ170.22 (4F,
s); m/z (EI) 282 (100, Mþ), 228 (8), 215 (10), 209 (16), 203 (26), 188
(21), 161 (26), 148 (19), 117 (16), 98 (16), 69 (17), 52 (31), 40 (34%).
C18H20N8Cl2F2O8 M¼585.32, triclinic, space group P-1,
a¼7.1932(8), b¼9.4900(11), c¼9.8025(11) Å,
a¼76.255(2)
b
¼
70.499(2),
g
¼74.909(2)ꢀ, V¼600.61(12) Å3, Z¼1,
r
¼1.618 g cmꢁ3
,
crystal size¼0.35ꢂ0.30ꢂ0.20 mm, T¼100 K; 6943 reflections mea-
sured, 3412 unique (Rint¼0.0289), which were used in all calcula-
tions, cut-off criterion I>2\s(I),
m
¼0.349 mmꢁ1, the final R and
wR(F2) were 0.0775, 0.1102 (all data), residual electron density max,
3.2.7. 1,4-Difluoro-2,3,5,6-tetrakis(pyrazol-1-yl)benzene (17)
min 0.392, ꢁ0.353 e Åꢁ3
.
Compound 17 was prepared according to the general procedure
using DMF as the solvent and 4 equiv of nucleophile at rt. To isolate
17, the crude reaction mass was separated by column chromato-
graphy on alumina, using CHCl3 as eluent. Isolated yield of product
was 55%, with colorless crystals from methanol, mp 257–258 ꢀC;
[Found: C, 57.13; H, 3.22; N, 29.60. C18H12F2N8 requires: C, 57.14; H,
3.20; N, 29.62%]; nmax (KBr) 3120, 1633, 1535, 1486, 1396, 1049, 952,
3.4.4. Cu(II) complex of 10
C12H8N4Cl2F2Cu M¼380.66, monoclinic, space group P21/c,
a¼15.915(4), b¼14.063(3), c¼13.560(3) Å,
b
¼106.267(4)ꢀ, V¼
2913.4(11) Å3, Z¼8,
r
¼1.736 g cmꢁ3
,
crystal size¼0.45ꢂ0.30ꢂ
0.20 mm, T¼120 K; 28,591 reflections measured, 6939 unique
(Rint¼0.0943), which were used in all calculations, cut-off criterion
858, 748 cmꢁ1
;
dH (300 MHz, CDCl3) 6.38 (4H, dd, J 2.5, 1.8 Hz, H-40
I>2\s(I),
m
¼1.884 mmꢁ1, the final R and wR(F2) were 0.1074, 0.1153
(pyrazolyl)), 7.47 (4H, dd, H-50 (pyrazolyl)), 7.67 (4H, dd, H-30
(pyrazolyl)); dC (63 MHz, CDCl3) 148.00 (dd, J 255.3 Hz, C-1,4),
142.42 (s, C-30 (pyrazolyl)), 132.24 (s, C-50 (pyrazolyl)), 127.01 (m, C-
2,3,5,6), 107.95 (s, C-40 (pyrazolyl)); dF (272 MHz, CDCl3) ꢁ153.74
(2F, s); m/z (EI) 282, 378 (53, Mþ), 243 (6), 216 (8), 189 (12), 175 (13),
162 (12), 150 (12), 124 (12), 112 (13), 100 (14), 94 (26), 79 (31), 69
(19), 52 (100), 39 (74%).
(all data), residual electron density max, min 0.989, ꢁ0.494 e Åꢁ3
.
3.4.5. Pd(II) complex of 6
C12H10N4Cl2Pd M¼387.54, monoclinic, space group P21/c,
a¼7.2352(4), b¼27.9533(16), c¼13.3461(8) Å,
b
¼100.0030(10)ꢀ,
V¼2658.2(3) Å3, Z¼8,
r
¼1.937 g cmꢁ3, crystal size¼0.40ꢂ0.25ꢂ
0.20 mm, T¼120 K; 24,879 reflections measured, 5741 unique